TRI-SCORE 对比 EACTS Lead Capture 的使用情况和统计数据

It is a simple, accurate and dedicated risk-score model to predict outcome after isolated tricuspid valve surgery for severe tricuspid regurgitation at an individual level according to the pre-operative clinical, biological and echocardiographic presentation. It has been developed from 466 consecutive adult patients who underwent an isolated tricuspid valve surgery on native valve for non- congenital severe tricuspid regurgitation at 12 tertiary French centers between January 1, 2007 and December 31, 2017. Its aim is to guide the clinical decision-making process in routine practice.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

To use this app you will need a unique activation code. Activation codes may only be purchased by the primary contact for your organization from the EACTS Exhibition Registration area via https://membership.eacts.org/ Scanned data may only be seen and downloaded by your organization’s primary contact following each day of the event. Please note: Do not delete the app from your device until the data has been successfully downloaded. For more information email info@eacts.co.uk.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

TRI-SCORE与EACTS Lead Capture排名比较

对比 TRI-SCORE 与 EACTS Lead Capture 在过去 28 天内的排名趋势

排名

没有可用的数据

TRI-SCORE 对比 EACTS Lead Capture 的排名,按国家/地区比较

对比 TRI-SCORE 与 EACTS Lead Capture 在过去 28 天内的排名趋势

所有品类

没有可用的数据

医疗

应用
热门国家/地区
排名
#205
- -
- -

通过免费试用版比较任何网站

开始使用
TRI-SCORE VS.
EACTS Lead Capture

十二月 11, 2024